Erratum: Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions (Clinical Chemistry and Laboratory Medicine (2014) 52: 2 (243-251) DOI: 10.1515/cclm-2013-0558);Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 2, 2014, Pages 243-251

  Wu, Shiyang ^a   Liu, Zhiming ^a   Liu, Suyan ^a   Lin, Li ^a   Yang, Weiwei ^a   Xu, Jiasen ^a  

^a SurExam Bio Tech Co Ltd Guangzhou Technology Innovation Base   (China)

Author keywords

Circulating tumor cells (Ctcs); Fluorescence in situ hybridization (Fish); Genetic abnormalities analysis; Isolation of ctcs by size

Indexed keywords

CD45 ANTIGEN;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER CELL CULTURE; CELL FRACTIONATION; CELL ISOLATION; CIRCULATING TUMOR CELL; COLON CANCER; CONTROLLED STUDY; ERYTHROCYTE; ESOPHAGUS CANCER; EXON; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE; LUNG NON SMALL CELL CANCER; LYSIS; MAGNETIC SEPARATION; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WILD TYPE;

ANTIGENS, CD45; CELL LINE, TUMOR; CELL SIZE; DNA; DNA MUTATIONAL ANALYSIS; ERYTHROCYTES; FEMALE; HEMOLYSIS; HEP G2 CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKOCYTES; MALE; MCF-7 CELLS; MUTATION; NEOPLASM STAGING; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84896301819     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-9999     Document Type: Erratum

References (21)

1. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell 2006;127:679-95
2. Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Scheibenbogen C, et al. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Clin Cancer Res 2007;13:1171-8
3. Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 2001;61:8845-50
4. Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res 2007;13:2992-7
5. Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2006;6:125-32
6. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005;23:1420-30
7. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:3213-21
8. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008;14:6302-9
9. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011;29:1556-63
10. Yu M, Stott S, Toner M, Maheswaran S, Haber D. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011;192:373-82
11. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13:920-8
12. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Letters 2007;253:180-204
13. Li GQ, Luo XD, He JY, Zhu ZY, Yu G, Qin HJ, et al. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue. Clin Chem Lab Med 2011;49:191-5
14. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008;359:366-77
15. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmüller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999;96:4494-9
16. Kraus J, Pantel K, Pinkel D, Albertson DG, Speicher MR. High-resolution genomic profiling of occult micrometastatic tumor cells. Genes Chromosomes Cancer 2003;36:159-66
17. Liu ZA, Fusi A, Klopocki E, Schmitte A, Tinhofer I, Nonnenmacher A, et al. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med 2011;9:70-8
18. Parkinson DR, Dracopoli N, Petty BG, Compton C, Cristofanilli M, Deisseroth A, et al. Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 2012;10:138-58
19. Stolpe A, Pantel K, Sleijfer S, Terstappen LW, Toonder J. Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 2011;71:5955-60
20. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009;101:61-6
21. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, et al. Isolation by size of epithelial tumor cells. Am J Pathol 2000;156:57-63.